The pharma company has received final approval from the US Food & Drug Administration to manufacture and market Risedronate Sodium Tablets USP, 5 mg, 30 mg and 35 mg.
Subscribe To Our Free Newsletter |
The pharma company has received final approval from the US Food & Drug Administration to manufacture and market Risedronate Sodium Tablets USP, 5 mg, 30 mg and 35 mg.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!